This site is not public yet

Enter the password to continue.

Skip to main content
Transperfect - Go to homepage

Global IMP Labeling, 50% Faster

One team handles label creation, regulatory review, and certified translation. Clinical supply teams get compliant IMP labels without juggling vendors.

  • 98.5% first-pass approval
  • 300+ languages, any country
  • 40-country labels in 2–3 days
Continuous testing for your products
Why TransPerfect

IMP labeling services that pass regulators the first time

IMP labeling affects your whole trial timeline, from drug label creation to customs clearance. One team keeps your studies on track in every country and any language.

  • On-Time First Dosing

    A dedicated clinical labeling regulatory and project management team is available 24/7/365 and cuts timelines by 50% to keep your study on track.

  • Get Labels Right, First Time

    Our 10-step ISO-certified translation process and character-by-character proof check are why our first-pass approval rate is 98.5% and label compliance is 100%.

  • One Team, Every Market

    One team handles regulatory review and translation across 300+ languages, removing the need to reconcile conflicting feedback across different vendors.

  • Build Once, Use Everywhere

    Every approved label and template is stored in a reusable library, so your next study starts with proven content. This lowers costs and cuts the risk of errors that trigger $100K–$700K reprints.

What’s included in our IMP labeling services

Every IMP label project follows the same four steps from protocol to proof, ensuring nothing is missed.

  • We build labels using your protocol, then check them against each country’s requirements. Labels arrive ready for in-country acceptance.

  • IMP label translation done by clinical-certified linguists using vetted regulatory glossaries, for accurate labels in any language.

  • To catch errors early, we check every proof character-by-character against the approved label and sign-off before print.

  • Submit, quote, track, communicate, and archive every project in one place, with full visibility and instant content reuse.

Case Study 2400x1290Case Study 2400x1290Case Study 2400x1290TransPerfect brand visual with two globes

Trusted by life sciences organizations worldwide

  • Pfizer
  • Sanofi
  • Astra Zeneca
  • Johnson&johnson
  • Moderna
  • Novartis
  • Takeda
  • V Vardis Logo
Who it’s for

Built for every team behind your IMP labels

CROs and CMOs often handle IMP label regulatory review and translation on their own, resulting in a fragmented process. TransPerfect consolidates and centralizes that work across every study partner, then checks every proof character-by-character before print.

  • Clinical supply labeling teams: Combine regulatory review and translation for all your CROs and CMOs under one team.
  • Clinical supply project managers: Track every country, revision, and partner status in one portal—no more chasing updates.
  • Clinical operations: Consistent labels across every study partner reduce the risk of shipments held up at customs.
  • Quality & regulatory teams: Audit-ready certificates from one ISO-certified, 21 CFR-compliant process across every CRO and CMO.
  • Emerging biotech wearing many hats: Consultative guidance from a partner who consolidates regulatory review and translation for you.
How it works

3 steps to regulatory-compliant IMP labels

  • Send us your protocol or SmPC, and we’ll create your master label.

  • We manage regulatory checks, translation, and proofing for you.

  • Get your final package: compliant, signed off, and ready to submit.

The impact

Proven results for IMP labeling

  • 35%
    Cost savings with tech-enabled workflows
  • 0
    Labels rejected by regulators to date
  • 98.5%
    First-pass regulatory approval rate

Get a demo built around your needs

Tell us what you're looking for. We'll get back to you within 24 hours.

How it works

  • 1We learn about your needs
  • 2A product expert schedules your demo
  • 3We show you the right solution
*
*
*
*
*
*
*
*

By sharing your personal data, you agree to our Privacy Policy.